Amanda H. McDowell
Overview
Amanda specializes in litigating on behalf of government contractors. She advises clients facing high-stakes investigations and allegations initiated by the federal government or relators under the False Claims Act. Amanda also assists clients in affirmatively asserting claims against the government and helps strategize with clients defending against government-asserted claims concerning issues that arise in the course of contract performance. Her expertise in federal procurement regulations enable her to guide clients through an array of procurement litigation disputes.
Career & Education
- University of Delaware, B.A., psychology and criminal justice, 2017
- The George Washington University Law School, J.D., with honors, 2021
- Virginia
- District of Columbia
- U.S. District Court for the Eastern District of Virginia
Professional Activities and Memberships
- Vice-Chair, ABA Section of Public Contract Law, Young Lawyers Committee August 2023 - August 2024
- ABA Section of Public Contract Law
- American Health Law Association
Honors and Awards
- Full Section Diversity Scholarship 2022-2024, ABA Section of Public Contract Law
Amanda's Insights
Client Alert | 5 min read | 10.08.24
In a novel False Claims Act (FCA) ruling, on September 30, 2024, Judge Kathryn Kimball Mizelle of the District Court for the Middle District of Florida upended decades of FCA jurisprudence in declaring the qui tam provisions of the FCA unconstitutional in U.S. ex rel. Zafirov v. Florida Medical Associates, LLC, 2024 WL 4349242 (M.D. Fla. Sept. 30, 2024). This decision follows Justice Thomas’ dissent in the recent Supreme Court decision, U.S. ex rel. Polansky v. Executive Health Resources, Inc., 599 U.S. 419 (2023), where he posited, “[t]here are substantial arguments that the qui tam device is inconsistent with Article II and that private relators may not represent the interests of the United States in litigation.” While Justice Thomas’ implicit constitutional challenge was not entirely new to FCA practitioners, including it in his Polansky dissent, with Justices Kavanaugh and Barrett in a concurring opinion noting their agreement that the Court should consider the constitutional questions in an appropriate case, swung wide open a door of opportunity for defendants and their counsel to attempt to dismiss FCA qui tam suits on constitutional grounds. Judge Mizelle’s decision in Zafirov is the first of its kind to actually dismiss a qui tam suit on constitutional grounds, and will likely lead to an avalanche of similar motions in nearly every non-intervened lawsuit brought by a relator.
Client Alert | 1 min read | 08.12.24
Publication | 08.07.24
The False Claims Act: Compliance issues in US government procurement and healthcare
Firm News | 2 min read | 06.11.24
Crowell Secures $131 Million Trial Win for Lockheed Martin in C-5 Aircraft Case
Representative Matters
- Representing government contractors in the defense and health care industries in FCA litigation and investigations initiated by whistleblowers and the government.
- Conducting internal investigations for private companies facing noncompliance and fraud allegations.
- Counseling government contractors on performance disputes and compliance issues, including potential terminations, overpayments, and cost accounting practices.
- Representing government contractors before the Armed Services Board of Contract Appeals in litigation defending compliance with cost accounting practices.
- Representing businesses engaged in federal procurement before the Boards of Contract Appeals in affirmatively asserting claims against the government.
Amanda's Insights
Client Alert | 5 min read | 10.08.24
In a novel False Claims Act (FCA) ruling, on September 30, 2024, Judge Kathryn Kimball Mizelle of the District Court for the Middle District of Florida upended decades of FCA jurisprudence in declaring the qui tam provisions of the FCA unconstitutional in U.S. ex rel. Zafirov v. Florida Medical Associates, LLC, 2024 WL 4349242 (M.D. Fla. Sept. 30, 2024). This decision follows Justice Thomas’ dissent in the recent Supreme Court decision, U.S. ex rel. Polansky v. Executive Health Resources, Inc., 599 U.S. 419 (2023), where he posited, “[t]here are substantial arguments that the qui tam device is inconsistent with Article II and that private relators may not represent the interests of the United States in litigation.” While Justice Thomas’ implicit constitutional challenge was not entirely new to FCA practitioners, including it in his Polansky dissent, with Justices Kavanaugh and Barrett in a concurring opinion noting their agreement that the Court should consider the constitutional questions in an appropriate case, swung wide open a door of opportunity for defendants and their counsel to attempt to dismiss FCA qui tam suits on constitutional grounds. Judge Mizelle’s decision in Zafirov is the first of its kind to actually dismiss a qui tam suit on constitutional grounds, and will likely lead to an avalanche of similar motions in nearly every non-intervened lawsuit brought by a relator.
Client Alert | 1 min read | 08.12.24
Publication | 08.07.24
The False Claims Act: Compliance issues in US government procurement and healthcare
Firm News | 2 min read | 06.11.24
Crowell Secures $131 Million Trial Win for Lockheed Martin in C-5 Aircraft Case
Insights
The False Claims Act: Compliance issues in US government procurement and healthcare
|08.07.24
Global Investigations Review
When Does Money Talk? ASBCA Says Claims With Financial Impact Not Automatically Monetary Claims
|06.20.23
Westlaw Today
- |
04.07.21
American Bar Association 50 Pub. Cont. L.J. 251
“What the Construction Industry Needs to Know About the Connecticut And Federal False Claims Acts”
|07.17.23
Client Training Presentation - "Compliance with Truthful Cost or Pricing Data Act"
|07.06.23
Feature Comment: The Top FCA Developments Of 2016 For Government Contractors
|01.11.17
The Government Contractor
Amanda's Insights
Client Alert | 5 min read | 10.08.24
In a novel False Claims Act (FCA) ruling, on September 30, 2024, Judge Kathryn Kimball Mizelle of the District Court for the Middle District of Florida upended decades of FCA jurisprudence in declaring the qui tam provisions of the FCA unconstitutional in U.S. ex rel. Zafirov v. Florida Medical Associates, LLC, 2024 WL 4349242 (M.D. Fla. Sept. 30, 2024). This decision follows Justice Thomas’ dissent in the recent Supreme Court decision, U.S. ex rel. Polansky v. Executive Health Resources, Inc., 599 U.S. 419 (2023), where he posited, “[t]here are substantial arguments that the qui tam device is inconsistent with Article II and that private relators may not represent the interests of the United States in litigation.” While Justice Thomas’ implicit constitutional challenge was not entirely new to FCA practitioners, including it in his Polansky dissent, with Justices Kavanaugh and Barrett in a concurring opinion noting their agreement that the Court should consider the constitutional questions in an appropriate case, swung wide open a door of opportunity for defendants and their counsel to attempt to dismiss FCA qui tam suits on constitutional grounds. Judge Mizelle’s decision in Zafirov is the first of its kind to actually dismiss a qui tam suit on constitutional grounds, and will likely lead to an avalanche of similar motions in nearly every non-intervened lawsuit brought by a relator.
Client Alert | 1 min read | 08.12.24
Publication | 08.07.24
The False Claims Act: Compliance issues in US government procurement and healthcare
Firm News | 2 min read | 06.11.24
Crowell Secures $131 Million Trial Win for Lockheed Martin in C-5 Aircraft Case